Facem România bine

Sunt 22 de ani de când sănătatea a devenit pentru noi mai mult decât o profesie, o pasiune.

In prezent ne desfasuram activitatea in : 155 puncte de recoltare,33 de laboratoare, 50 de clinici, 20 de hyperclinici, 10 spitale, 10 farmacii,9 centre de stomatologie, 4 maternitati si 1 banca celule stem.

Ca rezultat, am devenit cel mai mare operator privat de servicii medicale si nu incetam sa inovam, sa cunoastem, sa investim in medicii nostri si in echipamentele medicale si sa fim prezenti cat mai aproape de pacientii nostril din intreaga tara.

Iar acesta continuă să fie angajamentul nostru.

www.medlife.ro

IQVIA (formerly IMS health & Quintiles) is a FORTUNE 500 Company and the world’s largest integrated information and technology-enabled healthcare service provider. With a team of more than 65,000 professionals operating in more than 100 countries, we are dedicated to helping our clients improve their clinical, scientific and commercial results. IQVIA was named one of FORTUNE’s “Most Admired Companies” in 2018 due to our colleagues working together to advance healthcare by seamlessly connecting clinical and commercial execution to real-world outcomes.

As the world’s leading healthcare professional services provider we have excellent processes in place to recognize, reward and thank employees. Our recognition programs contribute significantly to the success of the company and more importantly generates a productive, innovative, engaging and rewarding place of work for all Employees.

The services we provide in Romania, since 1994 with a team of more than 190 employees, include market research, clinical research, technology solutions, consulting services, biostatistics and market access. (https://www.iqvia.com/ro-ro/locations/romania)

Clinerion is the worldwide leader in medical data analytics, radically improving efficiency in patient recruitment, increasing effectiveness in clinical research and accelerating the process of drug development to ensure a faster availability of medicines. With key tools for protocol feasibility testing, site feasibility testing, and patient search, Clinerion's solutions support patients and physicians in bringing early access to innovative medication; help hospitals to improve access to leading-edge sponsored trials; and enable life sciences companies to gain massive time and cost savings.

Clinerion big data also supports the generation of data for real-world evidence, and market access for precision medicines for rare and orphan diseases.

www.clinerion.com

SocraTec R&D – the CRO dedicated to quality and passion!

The idea which drives the members of the SocraTec family is always aiming for the right solution. It is not only perfection; often it is the combination of simplicity, usefulness and knowing what really counts.

22 years of experience with early phase clinical trials with a spectrum of know-how that leads your project from first-into-man to phase-II-patient studies and allows us to provide the best solution for you:

• A mid-sized CRO big enough to provide excellence on a highly-modern quality level fulfilling all internationally applied criteria for clinical trials
• Independent enough not to lose passion, enthusiasm and high-level identification with each and every clinical trial we run
• Our 140 employees ensure adequate resources which allows us to keep your timelines and to manage challenging trials – even if your development program enters later phases

Over the years we developed highly sophisticated niche experience in ophthalmology, gynaecology, and nephrology including dialysis, and also the fields of respiratory, cardiology, certain fields of oncology and internal medicine are well established. Our modern Clinical Pharmacology Unit with 60 beds in the middle of Germany with excellent technical equipment and highly experienced staff fulfills all needs of complex early phase development.

Our services are completed by project management, data management, statistics and pharmacokinetics as well as monitoring, auditing and medical writing – all what is needed to make your project succeed!

www.socratec-pharma.de

Milray MC - local CRO for the conduct of Clinical Trials from Moldova.

Milray MC have been involved in clinical trials since 2015. We are able to conduct phase I (BE/BA) II, III and IV CTs in the Republic of Moldova. Milray MC provides:

• Study Feasibilities and Strategy Consultation
• Projects coordination, all monitoring activities
• Development of the patient enrollment strategies
• Regulatory and Ethics Submissions
• Site and Investigator contract negotiations
• Monitoring and study oversight
• Clinical Study Supplies provisioning
• Investigator Meeting organization and GCP training of the investigators
• Services for pharmacovigilance and authorization of medicine in the Republic of Moldova
 

For more information you can visit our webpage at: www.milray.md

SGS provides clinical research and bioanalytical testing with a specific focus on early stage development and biometrics. Delivering solutions in Europe and in the Americas, SGS offers clinical trial (phase I to IV) services encompassing drug development consultancy, clinical project management and monitoring, biometrics, PK/PD modeling and simulation, and regulatory and medical affairs services. SGS has its own Clinical Pharmacology Unit in Belgium, including a human challenge testing facility and two phase I patient units based in Belgium and Hungary. SGS has a wealth of expertise in First-In-Human studies, viral challenge testing, biosimilars and complex PK/PD studies, with a therapeutic focus on infectious diseases, vaccines, and respiratory.

www.sgs.com/cro

ARENSIA EXPLORATORY MEDICINE (www.arensia-em.com) is a German research company with an innovative business model, designed to increase efficiency in Phase Ib, IIa and PROOF OF CONCEPT PATIENT trials, across numerous disease areas, by reducing the recruitment time and the number of sites/countries involved.

ARENSIA runs its own network of state-of-the-art Clinical Research Units located within large university hospitals in Eastern Europe, specialized on clinical execution of First-in-Patient / adaptive design exploratory protocols with highest degree of medical sophistication.

ARENSIA has an outstanding reputation in terms of safety and high quality of data (FDA/EMA inspected), enabling our pharmaceutical sponsors to advance their early phase clinical trials at unmatched speed.